A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSE(S) OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2

Clinical Trial Grant

Duke Scholars

Principal Investigator Emmanuel Benjamin Walter Jr. Pediatrics, General Pediatrics and Adolescent Health

Awarded By

Pfizer, Inc.

Start Date

June 9, 2021

End Date

June 8, 2023

Awarded By

Pfizer, Inc.

Start Date

June 9, 2021

End Date

June 8, 2023